Jaipur's Advit Jewels is experiencing a robust IPO debut, with investor demand surging on day one, leading to a 6.75 times subscription. Th...

Bajaj Auto fixed June 24 (Wednesday) as the record date for its Rs 5,633 crore share buyback. Only those shareholders who own the shares of...

Jaipur's handcrafted jewellery maker, Advit Jewels, is set to launch its IPO on June 23, 2026, with strong grey market interest indicating ...

Rising electricity demand and a strong investment cycle lift outlook for power companies.

Last week, Bajaj Auto said that its buyback committee decided on the record date for the purpose of determining the entitlement and eligibi...

This is the uncomfortable truth about company accounts. A number on a balance sheet is not always cash that will return, and a liability tu...

India Inc faces challenges ahead. Geopolitical tensions in West Asia and El Nino conditions may hurt company profits. Operating profit marg...

Charles Ellis highlights how stocks often decline together during market stress, challenging the perceived safety of diversification. The p...

Abakkus Mutual Fund is strategically allocating 30% to smallcaps within its Flexi Cap Fund, identifying mispriced opportunities despite str...

India's long-term growth outlook remains robust despite global geopolitical uncertainties and intermittent market volatility, supported by ...

Real estate stocks have surged nearly 9% in three days, with some analysts citing attractive valuations after a prolonged correction. This ...

Indian equities opened the week strong, with the Sensex and Nifty gaining nearly 1% each on positive global sentiment. Key stocks in focus ...

Monarch Networth Capital expects Nifty to reach 27,000-28,000 in 2026, driven by earnings recovery, capex growth and lower interest rates. ...

RBI’s FCNR(B) and ECB swap windows aim to boost liquidity, stabilise the rupee and ease funding costs for banks. Attractive returns for NRI...

Belligerence is back. Both the US and Iran are hitting each other and the statements from both sides do not auger well for a peace deal. Th...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

Invesco Mutual Fund's Hiten Jain offers a contrarian view, identifying the tech rout as a significant buying opportunity and dismissing bro...